Actinium Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.18

-0.02 (-1.67%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target +2,960.2% upside

Low Target $23.47

Average Target $36.11

High Target $39.96

Current Price $1.18

Current
$1.18

Target
$36.11

$23.47 $36.11 avg $39.96

Scenario Analysis

Bear Case

$23.47

1,889.0%

Low target

Base Case

$36.11

+2,960.2%

Avg target

Bull Case

$39.96

+3,286.4%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.74

-32.2% from high

52-Week Low

$0.74

+60.5% from low

Target vs 52W High

$36.11

+1,975.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%